AuntMinnie

MAY 12, 2024

Imaging Biometrics, a wholly owned subsidiary of IQ-AI, is highlighting results from a recent glioma study published in Neuroradiology. The study, led by Siem Herings, from Radboud University Medical Center in Nijmegen, the Netherlands -- Herings is a member of the lab of Dylan Henssen, MD, PhD -- validates the benefit of the company's IB Rad Tech workflow software for distinguishing treatment effect from tumor progression in post-treatment glioma patients.

Imaging 72

Imaging Medical IT 72

Open Medscience

MAY 12, 2024

Targeted Alpha Radionuclide Therapy precisely delivers potent alpha particles to tumors, maximising efficacy while sparing healthy tissues. The post The Role of Targeted Alpha Radionuclide Therapy in Modern Oncology appeared first on Open MedScience.

52

52

AuntMinnie

MAY 12, 2024

Ascelia Pharma is highlighting results from a phase III study for its liver imaging drug candidate, Orviglance. The study showed superior performance for visualizing focal liver lesions with Orviglance compared with unenhanced MRI, with statistical significance for all study three readers ( Ascelia Pharma is developing the drug as a contrast agent for use in liver MRI in patients with severely impaired kidney function; Orviglance has been granted orphan drug designation from the U.S.

MRI 52

MRI IT Imaging 52

JVIR

MAY 12, 2024

This study aims to characterize the relationship between ablation zone volume (AZV) and microwave ablation (MWA) energy in an in vivo porcine liver model following arterial embolization.

40

40

Advertisement

Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.

Clinic

AuntMinnie

MAY 12, 2024

Particular CT imaging findings can help clinicians diagnose negative effects of the use of adulterated cannabinoids, according to research presented at the American Roentgen Ray Society (ARRS) annual meeting. A team led by Nitai Bar, MD, of Rambam Healthcare Campus in Haifa, Israel, reported that suburothelial hemorrhage and intramural bowel hematomas found on CT imaging were indicative of coagulopathy linked to contaminated cannabinoids such as THC (tetrahydrocannabinol), CBD (cannabidiol), CBG

Public Health 40

Public Health Hospital Diagnose Healthcare 40